2012 ©
             Publication
Journal Publication
Title of Article Buparlisib and ponatinib inhibit aggressiveness of cholangiocarcinoma cells via suppression of IRS1-related pathway by targeting oxidative stress resistance 
Date of Acceptance 9 October 2024 
Journal
     Title of Journal Biomedicine & Pharmacotherapy 
     Standard SCOPUS Tier 1 
     Institute of Journal ELSEVIER 
     ISBN/ISSN  
     Volume 2024 
     Issue 180 
     Month
     Year of Publication 2024 
     Page 117569 
     Abstract  
     Keyword Bile duct cancer, Targeted therapy, Buparlisib, Ponatinib, Anti-cancer, Insulin receptor substrate 1 
Author
627070034-7 Miss WALEEPORN KAEWLERT [Main Author]
Medicine Doctoral Degree

Reviewing Status มีผู้ประเมินอิสระ 
Status ตีพิมพ์แล้ว 
Level of Publication นานาชาติ 
citation true 
Part of thesis true 
ใช้สำหรับสำเร็จการศึกษา ไม่เป็น 
Attach file
Citation 0

<
forum